Description
What it is
Co-formulation of cagrilintide and semaglutide for combined GLP-1/amylin research.
Mechanism
Combines GLP-1 agonism (semaglutide) with long-acting amylin signaling (cagrilintide).
Specifications
- Peptide content: 10mg / vial
- HPLC purity: ≥99.7%
- Form: Lyophilized powder
- Storage: 2–8°C, protected from light
- Shipping: Cold-chain dispatch from EU warehouse, same-day if ordered before 14:00 CET
Certificate of Analysis
Every batch ships with a downloadable Certificate of Analysis showing HPLC purity, mass-spec identity confirmation, and microbial/endotoxin pass results.






Reviews
There are no reviews yet.